Literature DB >> 8113854

The natural history of familial cavernous malformations: results of an ongoing study.

J M Zabramski1, T M Wascher, R F Spetzler, B Johnson, J Golfinos, B P Drayer, B Brown, D Rigamonti, G Brown.   

Abstract

Cavernous malformations are congenital abnormalities of the cerebral vessels that affect 0.5% to 0.7% of the population. They occur in two forms: a sporadic form characterized by isolated lesions, and a familial form characterized by multiple lesions with an autosomal dominant mode of inheritance. The management of patients with cavernous malformations, particularly those with the familial form of the disease, remains a challenge because little is known regarding the natural history. The authors report the results of an ongoing study in which six families afflicted by familial cavernous malformations have been prospectively followed with serial interviews, physical examinations, and magnetic resonance (MR) imaging at 6- to 12-month intervals. A total of 59 members of these six families were screened for protocol enrollment; 31 (53%) had MR evidence of familial cavernous malformations. Nineteen (61%) of these 31 patients were symptomatic, with seizures in 12 (39%), recurrent headaches in 16 (52%), focal sensory/motor deficits in three (10%), and visual field deficits in two (6%). Twenty-one of these 31 patients underwent at least two serial clinical and MR imaging examinations. A total of 128 individual cavernous malformations (mean 6.5 +/- 3.8 lesions/patient) were identified and followed radiographically. During a mean follow-up period of 2.2 years (range 1 to 5.5 years), serial MR images demonstrated 17 new lesions in six (29%) of the 21 patients; 13 lesions (10%) showed changes in signal characteristics, and five lesions (3.9%) changed significantly in size. The incidence of symptomatic hemorrhage was 1.1% per lesion per year. The results of this study demonstrate that the familial form of cavernous malformations is a dynamic disease; serial MR images revealed changes in the number, size, and imaging characteristics of lesions consistent with acute or resolving hemorrhage. It is believed that the de novo development of new lesions in this disease has not been previously reported. These findings suggest that patients with familial cavernous malformations require careful follow-up monitoring, and that significant changes in neurological symptoms warrant repeat MR imaging. Surgery should be considered only for lesions that produce repetitive or progressive symptoms. Prophylactic resection of asymptomatic lesions does not appear to be indicated.

Entities:  

Mesh:

Year:  1994        PMID: 8113854     DOI: 10.3171/jns.1994.80.3.0422

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  158 in total

1.  [Cavernomas of the central nervous system : Observational study of 111 patients].

Authors:  C Mayer; U M Mauer; G Bluhm; R Mathieu; C Hackenbroch; S Mayer
Journal:  Nervenarzt       Date:  2018-02       Impact factor: 1.214

2.  Familial cavernous malformations in a large French kindred: mapping of the gene to the CCM1 locus on chromosome 7q.

Authors:  L Notelet; F Chapon; S Khoury; K Vahedi; J P Chodkiewicz; P Courtheoux; M T Iba-Zizen; E A Cabanis; B Lechevalier; E Tournier-Lasserve; J P Houtteville
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

Review 3.  Management of hemorrhage from cavernous malformations.

Authors:  Sachin Batra; Karen Rigamonti; Daniele Rigamonti
Journal:  Curr Atheroscler Rep       Date:  2012-08       Impact factor: 5.113

Review 4.  Hyperintense perilesional edema in the brain on T1-weighted images: Cavernous malformation or metastatic melanoma? Three case reports and literature review.

Authors:  Nicolae Sarbu; Teresa Pujol; Laura Oleaga
Journal:  Neuroradiol J       Date:  2016-02-02

5.  Prospective Hemorrhage Rates of Cerebral Cavernous Malformations in Children and Adolescents Based on MRI Appearance.

Authors:  O Nikoubashman; F Di Rocco; I Davagnanam; K Mankad; M Zerah; M Wiesmann
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-13       Impact factor: 3.825

Review 6.  Cavernous malformations of central nervous system in pediatric patients: our single-centered experience in 50 patients and review of literature.

Authors:  Dattaraj Paramanand Sawarkar; Suveen Janmatti; Rajinder Kumar; Pankaj Kumar Singh; Hitesh Kumar Gurjar; Shashank Sharad Kale; Bhawani Shanker Sharma; Ashok Kumar Mahapatra
Journal:  Childs Nerv Syst       Date:  2017-06-20       Impact factor: 1.475

7.  Dynamic contrast-enhanced MRI evaluation of cerebral cavernous malformations.

Authors:  Blaine L Hart; Saeid Taheri; Gary A Rosenberg; Leslie A Morrison
Journal:  Transl Stroke Res       Date:  2013-09-21       Impact factor: 6.829

8.  High Prevalence of Spinal Cord Cavernous Malformations in the Familial Cerebral Cavernous Malformations Type 1 Cohort.

Authors:  M C Mabray; J Starcevich; J Hallstrom; M Robinson; M Bartlett; J Nelson; A Zafar; H Kim; L Morrison; B L Hart
Journal:  AJNR Am J Neuroradiol       Date:  2020-05-28       Impact factor: 3.825

9.  Management of intracranial cavernous malformation in pediatric patients.

Authors:  Jae-Whan Lee; Dong-Seok Kim; Kyu-Won Shim; Jong-Hee Chang; Seung-Kon Huh; Yong-Gou Park; Joong-Uhn Choi
Journal:  Childs Nerv Syst       Date:  2007-09-18       Impact factor: 1.475

10.  Two-hit mechanism in cerebral cavernous malformation? A case of monozygotic twins with a CCM1/KRIT1 germline mutation.

Authors:  Philipp Dammann; Ute Hehr; Sabine Weidensee; Yuan Zhu; Rüdiger Gerlach; Ulrich Sure
Journal:  Neurosurg Rev       Date:  2013-04-13       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.